Neuro

Acticor Biotech Receives European Medicines Agency (EMA) Endorsement on Key Parameters of ACTISAVE, Its Pivotal Phase II/III Study for Registration in Stroke

Approval of ACTISAVE design by the EMA to support a potential future marketing authorization application (MAA) for glenzocimab in Stroke Validation du choix d’un double critère d’évaluation principal : – Échelle de Rankin modifiée (mRS)1 – Échec (versus succès) défini par un handicap grave ou le décès, soit un score mRS 4-6 […]

Viz.ai and Cercare Medical Partner to Support Neurovascular Clinical Decision Making

New partnership incorporates latest perfusion technology into the Viz.ai platform SAN FRANCISCO–(BUSINESS WIRE)–Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced a partnership with Cercare Medical, which delivers next-level medical imaging with CT and MRI. The partnership will incorporate Cercare Perfusion, a fully-automated, simple-to-use, patient-specific perfusion […]

Tufts Medical Center Neurosurgeons and CereVasc Co-founders Honored by the Society of Vascular and Interventional Neurology for Innovation in Hydrocephalus Treatment

BOSTON, Nov. 21, 2022 /PRNewswire/ — Tufts Medical Center neurosurgeons Adel Malek, MD, PhD, Chief of Neurovascular Surgery, and Carl Heilman, MD, Neurosurgeon-in-Chief and Chairman of Neurosurgery, both Co-Founders of CereVasc, Inc. have been honored with the 2022 Innovation Award at the annual meeting of the Society of Vascular and Interventional Neurology (SVIN), for […]

CERENOVUS Reveals Positive Outcomes with Thrombectomy in Global Registry Studying Stroke-Inducing Blood Clots

EXCELLENT study demonstrates real-world benefits of CERENOVUS’ EMBOTRAP™ Revascularization Devices on clinical outcomes and first pass reperfusion IRVINE, Calif., Nov. 18, 2022 /PRNewswire/ — CERENOVUS, Inc., part of Johnson & Johnson MedTech*, today announced positive primary outcomes from the real-world EXCELLENT Registry focused on stroke-inducing blood clot removal by mechanical thrombectomy at the Society […]

Route 92 Medical Announces Expansion to New Manufacturing Site in Salt Lake City, Utah

SAN MATEO, Calif., Nov. 16, 2022 (GLOBE NEWSWIRE) — Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention, today announced expansion to a new high-volume manufacturing site in Salt Lake City, Utah. This 40,000 square foot site allows Route 92 […]

Viz.ai and Vastrax Join Forces to Accelerate Clinical Trial Enrollment

Partnership to accelerate enrollment and diversity in neurovascular clinical research SAN FRANCISCO–(BUSINESS WIRE)–Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced a strategic partnership with Vastrax, the leading full-service, vascular clinical research organization (CRO). Together, Viz.ai and Vastrax will accelerate clinical trial enrollment for research on novel […]

Announcing the launch of Medtronic Neurovascular Co-Lab™ Platform to accelerate innovation in stroke treatment

New Medtronic Neurovascular Co-Lab™ Platform drives collaboration and connections among start-ups, physicians, and institutions; aims to improve stroke treatment and access for patients worldwide DUBLIN, Oct. 26, 2022 /PRNewswire/ — Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the launch of Medtronic Neurovascular Co-Lab™ Platform designed to accelerate urgently needed innovation […]

Mentice and Acandis GmbH announce a 3-year agreement for Mentice Ankyras clinical support software solutions at a value of 8.9mSEK

Sweden–Gothenburg and Germany-Pforzheim, October 25, 2022 (https://news.cision.com/mentice-ab). GOTHENBURG, Sweden, Oct. 25, 2022 /PRNewswire/ — Mentice AB (publ), Gothenburg, a world leader in simulation solutions for image-guided interventional therapies, announced today that Acandis, Pforzheim, a leading innovator of minimal invasive devices for the treatment of neurovascular diseases, has signed a 3-year collaboration agreement to further develop the Acandis […]

New Initiative to Prevent, Treat and Beat Stroke Focuses on Health Equity, Heart-brain Connection

The American Heart Association’s Getting to the Heart of Stroke™ initiative, developed in conjunction with and supported by HCA Healthcare and the HCA Healthcare Foundation, focuses on preventing, treating and beating stroke by providing consumer and health care professional education nationwide, deepening collaboration between neurology and cardiology and equitably empowering communities […]

Shady Grove Medical Center Earns Certification in Breakthrough Stroke Treatment from The Joint Commission

ROCKVILLE, Md., Oct. 4, 2022 /PRNewswire/ — Adventist HealthCare Shady Grove Medical Center has earned national certification for mechanical thrombectomy, a minimally invasive surgical treatment for stroke that studies show can improve outcomes for many patients. Shady Grove Medical Center attained Thrombectomy-Capable Stroke Center (TSC) Certification from The Joint Commission, in collaboration with the […]